Company / Operating Cash Flow
FILANA THERAPEUTICS, INC. Operating Cash Flow History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$6.9M
FY2015
5-year range
-$14.7M / -$143.0K
FY2011-FY2015
Trend
+3.1%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow returned to growth in FY2015 after 2 years of decline, reaching -$7M.
Based on SEC 10-K filings.
-$7M in FY2015.
Declined from -$260,000 to -$7M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, operating cash flow increased 3.1% year-over-year.
- Peak operating cash flow was recorded in FY2012.
- Lowest operating cash flow in the period was in FY2011.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | -$6.9M | +3.1% |
| FY2014 | -$7.2M | -2658.1% |
| FY2013 | -$260.0K | -81.8% |
| FY2012 | -$143.0K | +99.0% |
| FY2011 | -$14.7M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026